Sertraline

Sertraline Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) on the WHO Model List of Essential Medicines. It selectively inhibits the membrane transporter SERT, increasing synaptic serotonin concentrations. Also exhibits weak dopamine reuptake inhibition (DAT), which may assist with fatigue and cognitive slowing. Favored in cardiac patients due to low arrhythmogenic risk. Indicated for major depressive disorder, panic disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and social anxiety disorder.

Sertraline Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) on the WHO Model List of Essential Medicines. It selectively inhibits the membrane transporter SERT, increasing synaptic serotonin concentrations. Also exhibits weak dopamine reuptake inhibition (DAT), which may assist with fatigue and cognitive slowing. Favored in cardiac patients due to low arrhythmogenic risk. Indicated for major depressive disorder, panic disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and social anxiety disorder.

Sertraline Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) on the WHO Model List of Essential Medicines. It selectively inhibits the membrane transporter SERT, increasing synaptic serotonin concentrations. Also exhibits weak dopamine reuptake inhibition (DAT), which may assist with fatigue and cognitive slowing. Favored in cardiac patients due to low arrhythmogenic risk. Indicated for major depressive disorder, panic disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and social anxiety disorder.

Alprazolam and Sertraline pairs an immediate-acting high-potency benzodiazepine with an SSRI. Alprazolam bridges the initial 2-4 week lag phase of antidepressant therapy by rapidly controlling severe anxiety, panicky distress, and insomnia, while sertraline elevates synaptic serotonin to alleviate core depressive illness. Indicated for major depressive episodes accompanied by prominent anxiety symptoms.

Alprazolam and Sertraline pairs an immediate-acting high-potency benzodiazepine with an SSRI. Alprazolam bridges the initial 2-4 week lag phase of antidepressant therapy by rapidly controlling severe anxiety, panicky distress, and insomnia, while sertraline elevates synaptic serotonin to alleviate core depressive illness. Indicated for major depressive episodes accompanied by prominent anxiety symptoms.